rosmarinic acid,
rosmarinic acid, (R-(E))-isomer,
rosmarinic acid,
20283-92-5,
Rosemary acid,
Labiatenic acid,
(R)-rosmarinic acid,
Rosmarinic-acid,
UNII-MQE6XG29YI,
Rosmarinate,
MQE6XG29YI,
CHEMBL324842,
CHEBI:50371,
MFCD00017740,
C18H16O8,
(R)-O-(3,4-Dihydroxycinnamoyl)-3-(3,4- dihydroxyphenyl)lactic acid,
3,4-Dihydroxycinnamic acid (R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethyl ester,
(2R)-3-(3,4-dihydroxyphenyl)-2-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]propanoic acid,
537-15-5,
Rosemaric acid,
(2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-propanoic acid,
(2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid,
(2r)-3-(3,4-Dihydroxyphenyl)-2-{[(2e)-3-(3,4-Dihydroxyphenyl)prop-2-Enoyl]oxy}propanoic Acid,
trans-Rosmarinic acid,
Benzenepropanoic acid, alpha-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-,
Meiji Red Perilla Polyphenol,
Rosmarinicacid,
Rosmarimic acid,
CCRIS 9361,
RM 21A,
3,4-Dihydroxycinnamic acid 2-ester with 3-(3,4-dihydroxyphenyl)lactic acid,
HSDB 7688,
NPLC 0542,
Rosmarinic acid, 2,
Rosmarinic acid, 96%,
AC1NQZ3E,
bmse000648,
AC1Q5R3O,
MLS000697677,
MEGxp0_000163,
SCHEMBL1650675,
SCHEMBL2028694,
ACon1_001068,
CHEBI:92370,
cid_5281792,
3-(3,4-DIHYDROXYPHENYL)ACRYLIC ACID-1-CARBOXY-2-(3,4-DIHYDROXYPHENYL)ETHYL ESTER,
CINNAMIC ACID, 3,4-DIHYDROXY-, 2-ESTER with 3-(3,4-DIHYDROXYPHENYL)LACTIC ACID,
DOUMFZQKYFQNTF-WUTVXBCWSA-N,
HMS2227A13,
HMS3266D13,
HMS3649C22,
HMS3675K16,
ZINC899870,
Benzenepropanoic acid, alpha-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (R-(E))-,
HY-N0529,
BDBM50133496,
AKOS015892734,
CCG-207919,
CCG-208268,
MCULE-4098643324,
NCGC00169708-01,
AN-14557,
AS-35341,
SC-44350,
SMR000445579,
LS-175479,
N1768,
W1784,
C01850,
225R532,
SR-01000946599,
I14-7740,
Q-100246,
SR-01000946599-1,
(2R)-O-caffeoyl-3-(3,4-dihydroxyphenyl)lactic acid,
F0001-0715,
93B6A3BF-927D-4C59-8A49-29BDBC87C194,
Rosmarinic acid, primary pharmaceutical reference standard,
Rosmarinic acid, European Pharmacopoeia (EP) Reference Standard,
Rosmarinic acid, >=98% (HPLC), from Rosemarinus officinalis L.,
Rosmarinic acid, United States Pharmacopeia (USP) Reference Standard,
(2r)-3-(3,4-dihydroxyphenyl)-2-{[3-(3,4-dihydroxyphenyl)acryloyl]oxy}propanoic acid,
(R)-2-[3-(3,4-Dihydroxyphenyl)acryloyloxy]-3-(3,4-dihydroxyphenyl)propionic acid,
(R,E)-3-(3,4-dihydroxyphenyl)-2-((3-(3,4-dihydroxyphenyl)acryloyl)oxy)propanoic acid,
(R,E)-3-(3,4-dihydroxyphenyl)-2-(3-(3,4-dihydroxyphenyl)acryloyloxy)propanoic acid,
3-(3,4-dihydroxyphenyl)-2-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}propanoic acid,
alpha-(((3,4-Dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxybenzenepropanoic acid,
[R-(+)]-?-[[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-3,4-dihydroxybenzenepropanoic acid,
Benzenepropanoic acid, +/--[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-3,4-dihydroxy-, (I+/-R)-,
Benzenepropanoic acid, .alpha.-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (R-(E))-,
Benzenepropanoic acid, .alpha.-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-3,4-dihydroxy-, (.alpha.R)-,
Labiatic acid,
Benzenepropanoic acid,
D05PTT,
rosmarinic acid, (R-(E))-isomer,
Rosmarinic acid, 98% - 5G 5g,
ACN-035532,
C18-H16-O8,
CID5281792,
CS-4261,
C041376,
R-(+)-2-(3,4-Dihydroxycinnamoyloxy)-3-(3,4-dihydroxyphenyl)propionic acid,
Rosmarinic acid, 98%, from Rosmarinus officinalis - 10MG 10mg,
Rosmarinic acid, 99%, from Rosmarinus officinalis L. - 250MG 250mg,
(2R)-3-(3,4-dihydroxyphenyl)-2-[3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]propanoic acid,
(alpha R)-alpha-[[(2E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-3,4-dihydroxybenzenepropanoic acid,
80225-53-2,
Benzenepropanoic acid, .alpha.-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-3,4-dihydroxy-, [R-(E)]-,
Propanoic acid, 3- (3, 4- dihydroxyphenyl)- 2- [3- (3, 4- dihydroxyphenyl)- 1- oxo- 2- propenyloxy]-,